
Results
22
Companies which are more than 50% undervalued based on analyst price target.
22 companies
China Resources Sanjiu Medical & Pharmaceutical
Market Cap: CN¥41.8b
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.
000999
CN¥24.97
7D
-1.4%
1Y
-20.9%
Chongqing Zhifei Biological Products
Market Cap: CN¥31.9b
A biopharmaceutical company, engages in the research and development, production, sale, and distribution of vaccine and biological products in China.
300122
CN¥13.16
7D
0.08%
1Y
-44.5%
Yili Chuanning BiotechnologyLtd
Market Cap: CN¥20.1b
Engages in the research, development, and industrialization of bio-fermentation technology and synthetic biology products in China and internationally.
301301
CN¥8.96
7D
2.3%
1Y
-27.7%
China Resources Double-Crane PharmaceuticalLtd
Market Cap: CN¥16.9b
China Resources Double-Crane Pharmaceutical Co.,Ltd.
600062
CN¥16.39
7D
1.3%
1Y
-19.2%
Mabwell (Shanghai) Bioscience
Market Cap: CN¥14.2b
A biopharmaceutical company, engages in the research and development, manufacture, and commercialization of biological products for oncology, immunology, bone disorders, ophthalmology, hematology, and infectious diseases in China and internationally.
688062
CN¥32.65
7D
14.5%
1Y
-8.8%
Zhejiang Wolwo Bio-Pharmaceutical
Market Cap: CN¥13.3b
Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd.
300357
CN¥25.00
7D
3.7%
1Y
-9.4%
InventisBio
Market Cap: CN¥12.1b
A clinical stage biotech company, focuses on areas of oncology, autoimmune diseases, and metabolic disorders to address unmet medical needs in China.
688382
CN¥20.71
7D
7.8%
1Y
-49.5%
BeBetter Med
Market Cap: CN¥12.1b
A biopharmaceutical company, engages in the research and development, and sale of drugs for oncology, metabolic diseases and central nervous system degenerative diseases.
688759
CN¥26.91
7D
17.1%
1Y
n/a
Inner Mongolia Furui Medical Science
Market Cap: CN¥11.8b
Inner Mongolia Furui Medical Science Co., Ltd.
300049
CN¥44.52
7D
-4.6%
1Y
-8.8%
Mayinglong Pharmaceutical Group
Market Cap: CN¥10.3b
Manufactures and sells Chinese and Western medicines in China and internationally.
600993
CN¥23.45
7D
-0.7%
1Y
-15.3%
Pacific Shuanglin Bio-pharmacy
Market Cap: CN¥10.2b
Engages in the research, development, production, and sale of blood products in China and internationally.
000403
CN¥10.92
7D
4.0%
1Y
-40.1%
Zhejiang Jolly PharmaceuticalLTD
Market Cap: CN¥10.1b
Engages in the research, production, and marketing of Chinese medicinal products in the People’s Republic of China and internationally.
300181
CN¥14.54
7D
3.0%
1Y
-27.3%
Chongqing Genrix Biopharmaceutical
Market Cap: CN¥9.7b
A biopharmaceutical company, engages in the research and development, production, and sale of antibody drugs in China.
688443
CN¥26.03
7D
11.1%
1Y
-25.9%
China Resources Boya Bio-pharmaceutical GroupLtd
Market Cap: CN¥7.9b
Engages in the research, development, production, and sale of blood products in China.
300294
CN¥15.72
7D
-0.6%
1Y
-42.4%
Amoy Diagnostics
Market Cap: CN¥7.2b
Engages in research and development, production, sale, and supporting services of tumor precision medical diagnostic products in China and internationally.
300685
CN¥18.68
7D
5.4%
1Y
-22.4%
KPC PharmaceuticalsInc
Market Cap: CN¥6.8b
A pharmaceutical company, engages in the research and development, production, marketing, and commercial wholesale of botanical drugs and natural drugs in the People’s Republic of China and internationally.
600422
CN¥9.40
7D
6.6%
1Y
-35.5%
Changchun BCHT Biotechnology
Market Cap: CN¥6.6b
Changchun BCHT Biotechnology Co. Ltd., a biopharmaceutical company, engages in the research and development, production, and sale of human vaccines in China and internationally.
688276
CN¥15.75
7D
4.6%
1Y
-34.8%
Hunan Jiudian Pharmaceutical
Market Cap: CN¥5.6b
Researches, develops, produces, and sells pharmaceutical products in China and internationally.
300705
CN¥11.36
7D
3.3%
1Y
-36.8%
Shenzhen Weiguang Biological Products
Market Cap: CN¥4.7b
Shenzhen Weiguang Biological Products Co., Ltd.
002880
CN¥20.86
7D
-0.4%
1Y
-28.9%
Hunan Fangsheng Pharmaceutical
Market Cap: CN¥4.3b
Engages in research, develops, produces, and sells traditional Chinese medicine industry and chemical pharmaceutical products in China.
603998
CN¥9.79
7D
3.6%
1Y
-13.0%
Kexing Biopharm
Market Cap: CN¥4.1b
A biopharmaceutical company, engages in the research and development, production, and sale of recombinant protein drugs and microecological preparations in China, the European Union, Brazil, the Philippines, and Indonesia.
688136
CN¥20.56
7D
9.8%
1Y
-54.8%
Zhejiang Starry PharmaceuticalLtd
Market Cap: CN¥3.9b
Engages in the research, development, production, and sale of active pharmaceutical ingredients in China and internationally.
603520
CN¥9.06
7D
1.6%
1Y
-18.1%